ERVIMMUNE – Trademark Portfolio

Entity Type: 99

ERVIMMUNE holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include ERVACCINE and ERVIMMUNE. The owner is based in LYON CEDEX 08.

CENTRE L�ON B�RARD 28 RUE LAENNEC

LYON CEDEX 08 69373 , FR

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ERVIMMUNE's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

44
Medical Services (3 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does ERVIMMUNE have?

ERVIMMUNE has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.

What trademark classes does ERVIMMUNE file in?

ERVIMMUNE files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are ERVIMMUNE's most well-known trademarks?

ERVIMMUNE's registered trademark portfolio includes well-known marks such as ERVACCINE and ERVIMMUNE. These are among 2 currently registered trademarks in the portfolio.

What is ERVIMMUNE's trademark registration success rate?

ERVIMMUNE has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.